QNRX — Quoin Pharmaceuticals Share News
0.000.00%
Brief: Cellect Biotechnology And Quoin Pharmaceuticals Announce Merger
U.S. STOCKS ON THE MOVE-Diana Shipping, Cellectis, Moderna
U.S. STOCKS ON THE MOVE-Baidu, Mediwound, Ironwood
Brief: Cellect Biotechnology Reports Q3 Loss Per Share $0.001
Brief: Cellect Biotechnology Commences Collaboration With XNK Therapeutics To Advance Novel Nk Cell-Based Therapies
Cellect Biotechnology: Rises on starting U.S. clinical trial of ApoGraft
Brief: Cellect Biotechnology Initiates U.S. Clinical Trial Of Apograft
Brief: Cellect Biotechnology Reports Second Quarter Financial And Operating Results
Brief: Cellect Biotechnology Reports Q1 Loss Per Share Of $0.002
Brief: Cellect Biotechnology Reports Q1 Loss Per Share Of $0.002
U.S. STOCKS ON THE MOVE-Oasis Midstream, L Brands, Diffusion Pharma
Cellect: Rises on deal to study its stem cell tech for COVID-19 patients
Brief: Cellect Biotechnology's Apograft To Empower Cellular Treatment Of Covid-19 Related Pulmonary Diseases
U.S. STOCKS ON THE MOVE-Cellect Biotechnology, Quidel, AMC Entertainment
Cellect: Soars on positive bone marrow transplant study data
Cellect Biotechnology: Gains on new patent allowance in Canada
Brief: Cellect Biotechnology Receives New Patent Allowance In Canada
Brief: Cellect Biotechnology Reports Fourth Quarter And Full Year 2019 Results
Cellect Biotechnology rises on new patent allowance in China